GMYPX
Price
$17.56
Change
+$0.08 (+0.46%)
Updated
Aug 13 closing price
Net Assets
431.77M
RMFCX
Price
$60.24
Change
+$0.18 (+0.30%)
Updated
Aug 13 closing price
Net Assets
109.66B
Interact to see
Advertisement

GMYPX vs RMFCX

Header iconGMYPX vs RMFCX Comparison
Open Charts GMYPX vs RMFCXBanner chart's image
Goldman Sachs Large Cap Value P
Price$17.56
Change+$0.08 (+0.46%)
VolumeN/A
Net Assets431.77M
American Funds American Mutual R3
Price$60.24
Change+$0.18 (+0.30%)
VolumeN/A
Net Assets109.66B
GMYPX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GMYPX vs. RMFCX commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMYPX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 110B vs. GMYPX (432M). RMFCX (1.26) and GMYPX (1.24) have matching dividends . GMYPX was incepted earlier than RMFCX: GMYPX (7 years) vs RMFCX (23 years). RMFCX (0.91) and GMYPX (0.88) have similar cost to investors . GMYPX is a more actively managed with annual turnover of: 51.00 vs. RMFCX (31.00). GMYPX has a lower initial minimum investment than RMFCX: GMYPX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 9.63 vs. GMYPX (0.52). RMFCX return over 5 years is better than : 55.38 vs. GMYPX (28.81).
GMYPXRMFCXGMYPX / RMFCX
Total Expense Ratio0.690.9176%
Annual Report Gross Expense Ratio0.880.9197%
Fund Existence7 years23 years-
Gain YTD4.98511.03445%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets432M110B0%
Annual Yield % from dividends1.241.2699%
Returns for 1 year0.529.635%
Returns for 3 years10.0123.7842%
Returns for 5 years28.8155.3852%
Returns for 10 yearsN/A79.87-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.280.07
+5.79%
Pacific Biosciences of California
EMCG13.670.33
+2.47%
Embrace Change Acquisition Corp
BCRX8.530.18
+2.16%
BioCryst Pharmaceuticals
MTSI125.990.54
+0.43%
MACOM Technology Solutions Holdings
PCTTU17.80N/A
N/A
PureCycle Technologies